Enjoy complimentary customisation on priority with our Enterprise License!
The cardiopulmonary stress testing systems market is estimated to grow at a CAGR of 6.92% between 2022 and 2027. The size of the market is forecast to increase by USD 2,103.24 million. The growth of the market depends on several factors, including the increasing number of heart specialty centers, rising incidence of cardiac diseases and growth of insurance providers, and increasing prevalence of CVDs.
This report extensively covers market segmentation by product (CPET systems, stress ECG, spect systems, stress blood pressure monitors, and pulse oximeters), end-user (hospitals, ambulatory surgical centers, and diagnostic centers), and geography (North America, Europe, Asia, and Rest of World (ROW). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.
To learn more about this report, Download Report Sample
Technavio categorizes the global cardiopulmonary stress testing systems market as a part of the global healthcare equipment market. The parent global healthcare equipment market covers products and companies engaged in the research and development of a variety of product categories, including capital equipment, instruments, implants, accessories, and consumables that are used for the diagnosis, monitoring, and treatment of various diseases. Our research report has extensively covered external factors influencing the parent market growth during the forecast period.
The increasing number of heart specialty centers is notably driving the market growth, although factors such as the high cost of stress testing devices may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Key Cardiopulmonary Stress Testing Systems Market Driver
The increasing number of heart specialty centers is notably driving market growth. The growing prevalence of CVDs across the globe is driving the growth of cardiac specialty centers, mainly in developed countries. The rising need to diagnose and treat CVDs is driving the demand for specialized outpatient cardiovascular centers. These centers/clinics offer the diagnosis and treatment of various CVDs, such as heart failure, hypertrophic cardiomyopathy, atrial fibrillation, hypertension, and valvular heart disease. The main aim of these clinics is to provide improved clinical outcomes at reduced costs and fulfill the need of patients.
These clinics are equipped with advanced devices for various diagnostic purposes. The availability of licensed and skilled physicians and other healthcare personnel in specialty cardiac centers has a positive impact on the clinical workflow and patient outcomes. Therefore, the rising number of specialized heart centers is expected to spur the growth of the global market during the forecast period.
Significant Cardiopulmonary Stress Testing Systems Market Trend
The growing integration of technologies is an emerging trend in the market. The global market has been witnessing an increase in the adoption of new technology platforms. Most providers have started focusing on virtual platforms to enable easy and better diagnoses from any location. Individuals and doctors are benefiting significantly from digital health devices and mobile health applications. Heart rate monitoring devices, coupled with mobile health applications, are likely to be adopted by many consumers and will have a positive effect on the healthcare industry. The development of new monitoring technologies has helped in improving disease diagnosis and treatment.
Technological advances have also allowed the flexibility and portability of these systems. Continuous digitization of record systems in physicians' offices and cardiology departments has led vendors to improve data connectivity for a range of management solutions. For instance, the CASE exercise testing system by GE HealthCare Technologies Inc. (GE Healthcare) enables quick and easy access to cardiac functions during exercise for better diagnostic confidence. Thus, technological advances in heart rate monitoring devices and their integration with other compatible technologies will have a positive impact on the growth of the global market during the forecast period.
Major Cardiopulmonary Stress Testing Systems Market Challenge
The high cost of stress-testing devices is a major challenge impeding market growth. Cardiopulmonary stress testing is performed in hospitals, clinics, and diagnostic laboratories to diagnose and assess patients with CVDs. The systems used for cardiopulmonary stress testing are expensive, owing to which medium and small hospitals and clinics find it difficult to purchase such products. The high cost of these systems also restricts their use in home care settings and small clinical laboratories. It may impact the cost of the overall diagnosis procedure. The cost of the systems used for stress testing varies depending on the type of product used for the diagnosis.
Furthermore, stress tests coupled with echocardiography or nuclear imaging are more expensive, which increases the out-of-pocket expenses of patients. Moreover, the radiation exposure from the radionuclide imaging used during the nuclear stress test (myocardial perfusion scan) carries more risks, which may limit the acceptance of this test among patients. These factors are expected to hamper the growth of the global market during the forecast period.
Key Cardiopulmonary Stress Testing Systems Market Customer Landscape
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Cardiopulmonary Stress Testing Systems Market Customer Landscape
Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Biosensors International Group Ltd. - The company operates under one segment. The company under this segment offers pioneering technology and proprietary technology. The key offerings of the company include various cardiopulmonary stress testing systems.
The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:
Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
The market share growth by the CPET segment will be significant during the forecast period. The CPET is used for the evaluation of the cardiopulmonary system. CPET, also known as CPX, is a noninvasive cardiopulmonary stress testing method designed to evaluate the activity of the heart and lungs during exercise. CPET is considered the gold standard by physicians for the functional assessment and evaluation of patients with chronic heart failure.
Get a glance at the market contribution of various segments Request a PDF Sample
The CPET systems segment was valued at USD 1,818.28 million in 2017 and continued to grow until 2021. CPET is an advanced diagnostic tool that can help physicians assess consolidative exercise responses involving the pulmonary, cardiovascular, and skeletal muscle systems. This test is widely used for a broad range of clinical applications for the evaluation of undiagnosed exercise intolerance and the determination of functional impairments. CPET systems are mainly used for CPET testing. Lightweight and portable CPET systems are mainly used in hospitals and clinics for cardiopulmonary stress testing. The increasing use of CPET systems as a validated tool for the diagnosis of patients with heart failure and the capability of these systems to perform distinct assessments by simplifying the precise and reliable measurement of the functional capacity of patients are the major factors fueling the adoption of these systems by physicians. Vendors in the global market are also focusing on the development of CPET systems. Hence, these factors will drive the growth of the global market during the forecast period.
For more insights on the market share of various regions Request PDF Sample now!
North America is estimated to contribute 36% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
North America accounted for the major share of the global market in 2022. This is mainly due to the rapid growth in the number of cardiac specialty centers and the favorable reimbursement scenario in the region. The high prevalence of CVDs in this region, coupled with the presence of skilled physicians to conduct advanced diagnostic procedures, is likely to drive the market in North America during the forecast period. Government organizations and other private organizations are taking various initiatives, such as funding and program launches, to increase the awareness of CVDs in North America. In the US, the American Heart Association (AHA) observed February 2022 as American Heart Month, which is a federally designated event to promote awareness about heart diseases and their early diagnosis. Such initiatives support the research on diagnosis and treatment procedures for evaluating and treating heart diseases. This is expected to augment the growth of the market in the region during the forecast period.
Favorable initiatives in North American countries are driving the growth of the market in the region. The National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) has developed an awareness program, The Heart Truth, to create awareness of heart diseases. With the help of this program, the National Heart, Lung, and Blood Institute works with national and community organizations and provides educational materials for the public and health professionals to increase awareness of heart diseases, especially among women, in the US. This will help in increasing the screening and diagnostic procedures for heart diseases and fuel the growth of the market in North America during the forecast period.
In 2020, with the outbreak of COVID-19, the regional market registered low growth. However, in 2021, with the gradual decline in the number of COVID-19 cases, lockdowns were lifted, leading to the resumption of non-essential services in hospitals, health clinics, and manufacturing units. This will fuel the demand for cardiopulmonary stress testing systems and drive the growth of the regional market during the forecast period.
The report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
Cardiopulmonary Stress Testing Systems Market Scope |
|
Report Coverage |
Details |
Page number |
176 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6.92% |
Market growth 2023-2027 |
USD 2,103.24 million |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
6.12 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 36% |
Key countries |
US, Germany, France, UK, and Japan |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
Becton Dickinson and Co., Biosensors International Group Ltd., Cardinal Health Inc., COSMED Srl, Fukuda Denshi Co. Ltd., General Electric Co., Halma Plc, Hill Rom Holdings Inc., Koninklijke Philips NV, MGC Diagnostics Corp., Nasiff Associates Inc., Neurosoft, Nihon Kohden Corp., Nonin Medical Inc., OSI Systems Inc., SCHILLER AG, Siemens Healthineers AG, SunTech Medical Inc., Thermo Fisher Scientific Inc., and Vyaire Medical Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.